Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Mutations in the WRN gene in mice accelerate mortality in a p53-null background.

http://www.ncbi.nlm.nih.gov/pubmed/10757812

Werner's syndrome (WS) is a human disease with manifestations resembling premature aging. The gene defective in WS, WRN, encodes a DNA helicase. Here, we describe the generation of mice bearing a mutation that eliminates expression of the C terminus of the helicase domain of the WRN protein. Mutant mice are born at the expected Mendelian frequency and do not show any overt histological signs of accelerated senescence. These mice are capable of living beyond 2 years of age. Cells from these animals do not show elevated susceptibility to the genotoxins camptothecin or 4-NQO. However, mutant fibroblasts senesce approximately one passage earlier than controls. Importantly, WRN(-/-);p53(-/-) mice show an increased mortality rate relative to WRN(+/-);p53(-/-) animals. We consider possible models for the synergy between p53 and WRN mutations for the determination of life span.

Pubmed ID: 10757812 RIS Download

Mesh terms: 4-Nitroquinoline-1-oxide | Animals | Blotting, Western | Camptothecin | Cell Aging | Cell Division | Cells, Cultured | Cloning, Molecular | DNA Helicases | Dose-Response Relationship, Drug | Embryo, Mammalian | Exodeoxyribonucleases | Fibroblasts | Gene Library | Life Expectancy | Mice | Mice, Knockout | Molecular Sequence Data | Mutation | Phenotype | Quinolones | RecQ Helicases | Spleen | Time Factors | Tissue Distribution | Tumor Suppressor Protein p53

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.